| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |